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Abstract: Colistin is considered to be an antimicrobial of last-resort for the treatment of
multidrug-resistant Gram-negative bacterial infections. The recent global dissemination of mobilized
colistin resistance (mcr) genes is an urgent public health threat. An accurate estimate of the global
prevalence of mcr genes, their reservoirs and the potential pathways for human transmission are
required to implement control and prevention strategies, yet such data are lacking. Publications
from four English (PubMed, Scopus, the Cochrane Database of Systematic Reviews and Web of
Science) and two Chinese (CNKI and WANFANG) databases published between 18 November 2015
and 30 December 2018 were identified. In this systematic review and meta-analysis, the prevalence
of mcr genes in bacteria isolated from humans, animals, the environment and food products were
investigated. A total of 974 publications were identified. 202 observational studies were included
in the systematic review and 71 in the meta-analysis. mcr genes were reported from 47 countries
across six continents and the overall average prevalence was 4.7% (0.1–9.3%). China reported the
highest number of mcr-positive strains. Pathogenic Escherichia coli (54%), isolated from animals (52%)
and harboring an IncI2 plasmid (34%) were the bacteria with highest prevalence of mcr genes. The
estimated prevalence of mcr-1 pathogenic E. coli was higher in food-animals than in humans and food
products, which suggests a role for foodborne transmission. This study provides a comprehensive
assessment of prevalence of the mcr gene by source, organism, genotype and type of plasmid.
Keywords: mobilized colistin resistance (mcr) genes; Escherichia coli; reservoir; food-chain; antibiotic
resistance; meta-analysis
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1. Introduction
The emergence of antimicrobial-resistant (AMR) bacteria has become one of the major threats
to global public health, food safety and social-economic development [1–3]. Global estimates of the
prevalence of bacteria that are resistant to critically important antimicrobials are required to implement
control and prevention strategies, yet such data are lacking.
Carbapenem-resistant bacteria have severely challenged antimicrobial therapy. Colistin (polymyxin
E) is a polycationic peptide antimicrobial that was isolated and characterized in 1949 [4]. It has been
reintroduced as a “last-line” therapeutic drug, for the treatment of infections in hospitalized patients
caused by carbapenem-resistant Gram-negative bacteria [5]. Before 2015, colistin resistance was
perceived to be due to regulatory changes mediated by chromosomal genes (phoPQ, pmrAB, and
mgrB) [6]. The discovery of plasmid-mediated mobilized colistin resistance (mcr) genes has had
an obvious influence on established antibiotic therapy regimens [7]. Lack of effective antibiotics
will inevitably compromise modern clinical medicine, especially the treatment of infectious diseases
and surgery.
There have been an increasing number of reports on the identification of mcr genes in many
bacterial species across the world since this gene was first characterized [8–10]. One retrospective
study from China, showed the presence of the mcr-1 gene in E. coli isolated from poultry in the 1980s
and suggested that the emergence of the gene may be linked to the use of colistin as a growth promoter
in the poultry industry [11]. Multiple mcr genes (mcr-1 to -8) in addition to several mcr-1 variants
have been reported [12]. A recent study by Carroll et al. [13] described mcr-9, a novel mcr homologue
in a multidrug-resistant (MDR) Salmonella Typhimurium strain isolated from a human patient in
United States.
The mcr genes have been detected in a wide range of plasmid types such as IncI2, IncHI2, IncX4,
IncP, IncF, and IncY. The bacteria that carry these genes have been isolated from pigs, poultry, and cattle
and also from food products derived from these animals such as pork, chicken and beef, in addition
to many environmental sources such as hospital sewage, rivers, and seas, [8]. Few studies have
conducted an integrated analysis among animal hosts, bacterial species or genotypes, and plasmid
types. Investigations on the role of the environment and/or a foodborne pathway for mcr dissemination
are patchy and sometimes vague.
The co-occurrence of mcr and other resistance genes, especially those that confer resistance to
carbapenem drugs [14], have already been reported. While this highlights the limitation of therapeutic
choices, a recent study suggested that treatment with colistin in combination with other antibiotics is
still effective against mcr-harboring bacteria in an animal infection model [15].
The objectives of this study were to determine (1) the global distribution of mcr genes; (2) potential
reservoirs including the environment, animal hosts, humans, bacterial species, genotype, and plasmid
type and (3) to perform an analysis on antibiotic resistance patterns in isolates obtained from the
different reservoirs.
2. Methods
2.1. Search Strategy and Selection Criteria
In compliance with PRISMA recommendations [16] (Figure 1), we conducted a systematic
literature review and meta-analysis study. Four English (PubMed, Scopus, the Cochrane Database
of Systematic Reviews, Web of Science) and two Chinese (CNKI and WANFANG) databases were
searched individually for the published papers. We focused on those published between 18 November,
2015 (first publication on mcr gene discovery) and 30 December, 2018. We used some keywords to
search relevant publications in both English and Chinese databases. The search key words, or strings,
were “mcr genes and polymyxins”, “prevalence of mcr genes”, “occurrence of mcr genes”, “incidence
of mcr genes”, “mcr-1 OR mcr-2 OR mcr-3 OR mcr-4 OR mcr-5 OR mcr-6 OR mcr-7 OR mcr-8 OR variant
mcr genes” “colistin resistance”, and “plasmid-mediated colistin resistance”.
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and meta-analysis.
2.2. Study Selection
The systematic review was performed by four reviewers. Two reviewers (ME and NP) evaluated
the data from English databases, and two reviewers (YL and HP) evaluated the data from Chinese
databases. The searc results were imported into the Endnote 7 references manager distributed by
Clarivate Analytics and de-duplicated. Initial screening was done on the basis of title and abstract.
Full text of the publications selected after initial screening was btained from the library of Zhejiang
University for data extraction. The relevant variables such as title, authors list, country of sampling,
period of study, sampling reservoir, animal host, bacteria species and genotype, plasmid type, date of
sampling and antimicrobial resistance pattern (if available) were extracted and arranged in a MS Excel
spreadsheet specially formatted for the purpose.
2.3. Data Categorization
The scheme of data categorization summarized in Table 1 are shown with details in Supplemental
Table S1 and Supplemental Tabl S2. The mcr variants among the various bacterial genera and species
were also summ rized (Table S3). Th E. coli strains w re split into two groups as pathogenic and
non-pathogenic E. coli. Any known pathogenic serotype or variants such as O157 [17], or those
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that have been reported as the causative agent of human or animal infection [18] or as a pathogenic
E. coli (in the selected publication) were categorized into pathogenic E. coli group (P. E. coli), whereas
isolates which were reported from non-clinical cases and did not cause disease were categorized as a
non-pathogenic E. coli.
Table 1. Scheme of the data categorization.
Categories Includes Sub-Includes
Environmental Sewage, river, and sea watersamples
Animal
Pig, poultry, cattle, and other
animal samples
Poultry Chicken, turkey, and muscovy duck
Other animals Migratory birds, penguins, reptiles, kelp gullsand dogs
Food
Pork, chicken meat, beef, and
other foods samples
Other foods Vegetables and foods from unknown sources
Human
Fecal and other samples
Other samples Blood, urine, pus, sperm, abdominal andperitoneal fluids, sputum, and ascites
Harboring bacteria
Pathogenic E. coli (P. E. coli),
Salmonella spp., Klebsiella
pneumoniae, other bacteria
Salmonella spp. S. Typhimurium, S. Paratyphi B, S. Virchow,S. Rissen, S. Indiana and S. Derby, S. London
Other bacteria
Citrobacter freundii, non-pathogenic. E. coli,
Citrobacter braakii, Enterobacter cloacae, Shigella
sonnei, Aeromonas veronii, Enterobacter
aerogenes, Cronobacter sakazakii, Kluyvera
ascorbata, Acinetobacter, Klebsiella variicola,
Moraxella pluranimalium, Klebsiella oxytoca,
Providencia alcalifaciens, and Raoultella
ornithinolytica
Plasmid types IncI2, IncHI2, IncX4
Other plasmids IncF, IncFIB, Inck, Incx, IncP, IncFII, and ColE
2.4. Data Analysis
We calculated the frequency of identification of mcr genes and their relationship with different
reservoirs (human, animal hosts, bacteria, plasmid types) and antibiotic resistance pattern for
mcr-positive bacteria. Pivot table function of Microsoft Excel 2016 was used to calculate the descriptive
analysis (as a percentage), and the prevalence of mcr-harboring strains among the total strains including
95% confidence intervals (CIs), the total number of resistant isolates (number of resistant isolates/total
number of positive isolates from same species) to each individual antimicrobial drug. Additionally,
the sequence type (ST) of pathogenic E. coli (P. E. coli) harboring mcr-1 as the most frequent bacteria
was also calculated. Student’s T-test and graphs were performed using GraphPad Prism 7. Among
202 articles that were included in the systematic review, only 134 articles mentioned the total number
of strains and were included in a cumulative prevalence analysis. We excluded all the case studies,
and any articles that did not mention the total number of strains.
The prevalence results are shown in percent with the 95% CI in parenthesis. The meta-analysis
and Forest plotting were done using Open Meta-Analyst software. The data were analyzed in binary
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random model effects at 95% confidence interval. The values of heterogeneity (I2) [19] across the
studies at 25%, 50%, and 75% were considered a slow, moderate, high heterogeneity, respectively.
3. Results
3.1. Data Selection
A total of 925 papers resulted from the initial search in English databases, 30 from Chinese
databases and 19 additional English articles were included after reference search. After screening,
based on the title and abstract, 691 (614 irrelevant, 69 repeated articles, and 8 reviews) were excluded.
The remaining 283 publications were assessed for eligibility, and a further 80 (54 had no data about mcr
genes and 26 publications where bacteria with mcr genes were not isolated from the samples) were
excluded. We included 202 publications for synthesis of the systematic review. A meta-analysis of P.
E. coli, Salmonella, and K. pneumonia harboring the mcr-1 gene was carried out with 71 publications. One
hundred and thirty-one were excluded (58 papers had less than 20 samples, 57 papers were on bacteria
other than pathogenic E. coli, Salmonella, and K. pneumoniae and 2 papers were not related to mcr-1
data). (Figure 1). We included 134 articles in the average prevalence analysis for the countries and the
burdens. Ninety-eight of these 134 articles (73.3%) used a targeted PCR method and 36 (26.7%) used a
selective culture media method (Table S4). We calculated the total number of isolated strains and the
total numbers of mcr harboring strains in the selected articles. The prevalence (%) was calculated as
(total number of isolated mcr harboring strains/the total number of isolates in each article).
3.2. Global Dissemination of mcr Genes
The current global distribution of mcr genes, in relation to the various hosts, bacteria and plasmid
types showed significant geographic segregation (Figure 2). A total of 5191 mcr-gene-harboring strains
were reported in 202 publications. Of these, 4917 were of the mcr-1 type while the remaining 274
were other variants. White colored countries in Figure 2 refer to countries that have not yet reported
studies on mcr genes. P. E. coli (53%) among all bacteria, and animals (53%) among all hosts, were
the most frequent mcr carriers reported globally. IncI2 (34%) plasmids were the most frequently
reported plasmids.
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3.3. Global Prevalence of mcr Genes by Sampling Source as a Reservoir
The cumulative average prevalence of mcr genes was 4.6% (0.1–9.3%), with the highest in
environment 22% (2.8–47.8%), followed by animals 11% (0.3–22.4%), food 5.4% (0.6–11.6%), and
humans 2.5% (0.1–5.1%) (Figure 3A). China shares a similar pattern with the global picture and showed
an overall prevalence in the environment of 39% (8.3–88.5%); animals 14% (0.7–30%); humans 4.5%
(0.2–9.3%), and food products 4.9% (0.7–10.7%). Vietnam also has a very similar pattern to China,
14.7% from animals, 4.5% in humans and 4.9% in food products (Figure S1).
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Figure 3. Prevalence of mcr genes from ultiple sources (A), bacteria (B), plasmids (C) and pathogenic
E. coli sequence type (ST) ( ). ( ) contain the positive strains/total strains Values in (A and B) are the
prevalence of positive strains in the total number of strain , in (C), the value is the prevalence of plasmid
types and in (D) P. E. coli harboring mcr-1 shows the prevalence of diff rent sequenc types (ST) of th
positive isolates.
3.4. Global Prevalence of mcr Genes by Bacterial Genera and Species
There were 15 bacterial genera, mainly of the Enterobacteriaceae (11/15) (Supplemental Table S2,
Supplemental Table S3), in which the presence of mcr has been reported to date. E. coli (non-pathogenic
and pathogenic types) followed by Salmonella, Klebsiella and Aeromonas were the most common bacteria
from which themcr genes have been isolated. Non-pathogenic E. coli showed the highestmcr prevalence
of 15.2%. The isolation rate of E. coli varies dramatically; China leads in terms of the numbers of reports
made. The mcr-1 gene was identified in 4917 strains, 274 strains had a variant mcr genes.
3.5. Types of mcr Gene and Their Associated Reservoir
The environmental samples had the highest prevalence of strains that carried the mcr-gene, 22.3%
(2.8–47.8), although they had the lowest positive detections (3%, n = 178), likely due to lack of studies
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that looked at environmental sources. 2067 (39%) isolates were from human sources and the lowest
prevalence 2.5% (0.1–5.1) was observed in these samples (Figures 3A and 4A). Of the isolates, 62%
were from clinical patients with an infectious disease and 38% were from asymptomatic carriers.
Seventy-seven percent of the isolates were from feces. Isolates from pigs (among the animals) and
chicken meat (among the foods) had the highest rate of mcr gene detection (Figure 4A). Live animals
(swine, poultry, and bovine) had a higher frequency of mcr genes than isolates from meat samples
(pork, chicken meat and beef). Concerning the entire host community, P. E. coli with mcr-1 was the most
common pathogen-mcr association (Figure 3A, Figure 4A). IncI2 was the most prevalent plasmid type
at 28.5% (2.5–95.8) as well as the most frequent type associated with poultry, human, environmental
and food isolates. The IncHI2 plasmid type was associated with isolates from animals (Figure 3C,
Supplemental Figure S2B). There was no significant difference between the hosts in total number of
isolates and the total number of plasmids (p > 0.05, Student T-test).
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Table 2. Antibiotic resistance of isolates that harbor mcr genes.
Sources CST TGC GEN CIP AMK CTX CFX TET TMP-SMX FOS MEM IMP AMP KAN
Human
P. E. coli
98.69%
(993)
3.39%
(59)
59.55%
(178)
44.09%
(973)
22.60%
(146)
79.61%
(152)
83.72%
(43)
96.43%
(28)
83.08%
(65)
48.62%
(109)
2.76%
(979)
2.76%
(979)
93.33%
(150)
95.00%
(20)
Swine 99.37%(158)
100.00%
(3)
86.67%
(15)
90.91%
(11)
6.06%
(33)
47.06%
(34)
100.00%
(3)
100.00%
98)
98.98%
(98)
100.00%
(27)
43.64%
(55)
40.38%
(52)
43.75%
(48)
80.65%
(33)
Poultry 100.00%(125)
0.00%
(38)
61.90%
(21)
97.58%
(124)
16.67%
(18)
100.00%
(55)
100.00%
(3)
96.43%
(56)
98.04%
(51)
100.00%
(54)
0.00%
(3)
0.00%
(3)
94.59%
(74)
26.32%
(19)
Bovine 100.00%(17)
0%
(5)
80.00%
(5)
100.00%
(6)
NA 83.33%
(6)
83.33%
(6)
100.00%
(6)
100.00%
(5)
0.00%
(5)
0.00%
(1)
0.00%
(1)
100.00%
(6)
100.00%
(1)
Food 97.83%(45)
100.00%
(1)
33.33%
(18)
69.57%
(7)
100.00%
(1)
81.25%
(16)
100.00%
(5)
84.21%
(19)
87.50%
(24)
100.00%
(3)
0.00%
(7)
0.00%
(7)
81.25%
(16)
40.00%
(5)
Environmental 87.10%(31)
33.33%
(24)
60.00%
(5)
36.00%
(25)
72.73%
(11)
100.00%
(1)
100.00%
(2)
100.00%
(3)
100.00%
(1)
100.00%
(1)
9.09%
(30)
9.09%
(33)
100.00%
(3) NA
Human
K. pneumoniae
100.00%
(36)
21.40%
(7)
91.67%
(12)
63.64%
(11)
33.33%
(6)
91.67%
(12)
100.00%
(6)
100.00%
(4)
60.00%
(5)
66.67%
(3)
53.85%
(13)
53.85%
(13)
90.00%
(10)
33.3%
(6)
Animals 100.00%(13)
NA 100.00%
(4)
100.00%
(4)
100.00%
(1)
100.00%
(4)
100.00%
(4)
91.67%
(11)
100.00%
(9)
NA 0.00%
(5)
0.00%
(5)
100.00%
(4)
0.00%
(1)
Human
Salmonella
100.00%
(32) NA
43.59%
(39)
24.14%
(29) NA
65.52%
(29)
100.00%
(1)
80.65%
(31)
63.16%
(19) NA
0.00%
(2)
0.00%
(2)
90.00%
(30)
90.00%
(30)
Animals 100.00%(36) NA
96.55%
(29)
97.30%
(36)
96.4%
(26)
87.50%
(8)
0.00%
(36)
100.00%
(10)
100.00%
(34)
96.15%
(26)
0.00%
(2)
0.00%
(2)
100.00%
(54)
100.00%
(3)
Human
Other
isolates
60.00%
(5)
100.00%
(1)
100.00%
(3)
75.00%
(4)
66.67%
(3)
100.00%
(1)
0.00%
(2)
100.00%
(2) NA NA
14.2%
(6)
75.00%
(5)
100.00%
(2) NA
Animals 96.34%(273)
0.00%
(152)
31.84%
(223)
76.50%
(234)
1.94%
(155)
93.33%
(165)
99.34%
(152)
96.41%
(232)
NA 100.00%
(3)
0.86%
(233)
48.07%
(231)
100.00%
(71)
100.00%
(3)
( ) contain the number of isolates. Antibiotics: CST—Colistin, TGC—Tigecycline, GEN—Gentamicin, CIP—Ciprofloxacin, AMK—Amikacin, CTX—Cefotaxime, CFX—Cefoxitin,
TET—Tetracycline, TMP-SMX—Trimethoprim-sulphamethoxazole, Fos—Fosfomycin, MEM—Meropenem, IMP—Imipenem, AMP—Ampicillin, KAN—Kanamycin.
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As compared to 4917 (95%) isolates that carried mcr-1, only 274 (5%) carried one of the other
variant genes (mcr-2 to mcr-8). Supplemental Figure S3 showed that mcr-3 had a wide distribution
in water, animal, food, and human isolates. P. E. coli had the highest frequency of mcr genes, except
for mcr-5 which was mainly isolated from Salmonella species. In addition, mcr-7 and mcr-8 were only
reported in K. pneumoniae isolated from animals. IncI2 was the most common plasmid type in all hosts
except animals. IncHI2, IncX4, CoIE and IncI2 plasmid types, had the highest frequency in mcr-2, 3, 5
and 7 respectively.
3.6. Antimicrobial Resistance in mcr-Positive Bacteria
The results from antimicrobial susceptibility tests were different in the various studies because of
the different antimicrobial agents tested, so we included only the resistance profiles of mcr-harboring
bacteria in our analysis. Eighty-four percent (170/202) of the articles documented the antimicrobial
resistance assays, and a high occurrence of co-resistance was observed (Table 2). All water and food
isolates were susceptible to the two carbapenem drugs (imipenem and meropenem). P. E. coli isolated
from poultry and bovine were susceptible to tigecycline, unlike those from swine, which were resistant
to tigecycline. Human P. E. coli were susceptible to tigecycline and showed low resistance (2.76%)
to the carbapenem drugs. Klebsiella pneumoniae strains from humans were resistant to carbapenem
drugs (53.85%) and none of the isolates from animals were resistant. All of the Salmonella isolates were
susceptible to carbapenems.
3.7. Role of mcr-1 Pathogenic E. coli, Salmonella, and Klebsiella in mcr Gene Dynamics
Because of their public health significance, we focused on pathogenic E. coli, Salmonella, and
Klebsiella, in the meta-analysis studies. The average prevalence of mcr-1-harboring bacteria was
calculated by a meta-analysis of 71 publications (Figures 5 and 6). The analysis showed more
heterogeneity in pathogenic E. coli (I2 = 97.65%) with an average prevalence of 23% (20–26, p < 0.001)
(Figure 5) than Salmonella (I2 = 80%) with an average prevalence of 6% (2–11, p < 0.001) (Figure 6A)
and Klebsiella (I2 = 62%) with an average prevalence of 8% (3–12, p < 0.001) (Figure 6B). Additionally,
the average prevalence of pathogenic E. coli in humans was 0.7% (0.5–0.9, p < 0.001), in animals it was
16.8% (13–20.6, p < 0.001) and in foods it was 7.1% (3.4–10.8, p < 0.001). The highest heterogeneity was
among the papers that dealt with animals’ isolates (I2 = 97.65%) and the lowest was in those isolates
from food (I2 = 90.03%), and the humans (I2 = 92.83%) (Figure 5). The comparative analysis has not
been made for humans, animals and foods of Salmonella and Klebsiella because of unavailability of their
comparative data. Several studies included data on multiple hosts.
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3.8. Common ST of P. E coli with mcr-1
The frequency of P. E. coli STs harboring mcr-1 varied among different sources (Figure 7). ST10,
the dominant ST in both animals and water, is the most common ST of those that carrying mcr-1
globally, also has the highest prevalence 17.5% (2.9–39.4) (Figure 3D). ST116 the most abundant ST in
humans, has been reported only from China (Figure 7A).
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4. Discussion
Since the first isolation of mcr-1 in China in 2011 [7], mcr-harboring bacterial isolates have been
reported from six continents (Asia, Europe, Africa, North America, South America, and Oceania) and
over 27 bacterial species. The majority of studies have been conducted in China but mcr-harboring
isolates were also reported from many European countries such as the UK, Spain, and Italy. The
reason for the increasing reports may be due to long-term use of polymyxins in veterinary medicine
in these countries. It should be noted that before 2005 there were no reports that identified the
mcr-harboring isolates and most of the isolates currently reported to be mcr positive are historical
isolates, dating back to as early as 1980. Similarly, global trade and travel either to countries with high
or unknown prevalence (Canada [20], U.S. [21] and Japan [22]), importation of food from infected
countries (Japan [23] and Tunisia [24]), and over-prescription of colistin in human medicine to treat
highly resistant clinical pathogens (i.e., Argentina [25]) are also the suggested causes. To date, several
other mcr gene variants have been identified, including mcr-2, -3, -4, -5, -6, -7, and -8, which share
81%, 32%, 34%, 36%, 83%, 35%, and 31% amino acid sequence identity, respectively, with mcr-1 [26].
Recently mcr-9 which is closely related to mcr-3 was reported [13]. Minor variants have been reported
for each of mcr-2, -4, and -5, whereas there are more than 10 mcr-3 variants [26]. Among other mcr
genes, the earliest mcr-3 was discovered in 2005 in Germany [27]; whereas mcr-2 (2009), -4 (2013), -5
(2011), -6 (2015), and -7 (2014) [26–29], were identified in strains collected over the past decade. This
supports the hypothesis that mcr genes existed far earlier than first reported. Moreover, all mcr genes
except (mcr-6 and mcr-9) have been detected in samples from China. Thus far, mcr-2 (Belgium and
Spain), mcr-3 (Brazil, Denmark, France, Germany, Japan, Spain and Thailand), mcr-4 (Italy and Spain),
mcr-5 (Colombia, Japan, Spain and Germany), and mcr-9 (US) [27,29–37].
A report by Biswas et al. [38] demonstrated that mcr-3-harboring Salmonella Typhimurium ST34 is
highly likely to be linked with international travel. Two recent studies reported that Moraxella spp. a
common pathogen associated with animals, but that may also be human pathogens, has been identified
as a potential source of mcr-like genes [36,39]. A recent study described that the newly found mcr-9
gene in Salmonella Typhimurium, from a clinical isolate in USA, was capable of conferring phenotypic
resistance to colistin in Enterobacteriaceae, making it a relevant concern to public health [13]. Most
of the studies where the mcr genes were reported included a screening approach for MDR strains
(a pre-selected population of strains). Different screening methods to isolate mcr positive organisms
were conducted in each study, the bibliography analyses may be biased by the size of the countries,
missing data and their scientific intentions according to their priorities. These limitations might
influence the global and individual country prevalence interpreted in current study.
4.1. Role of mcr-Positive Bacteria via Food-Chain Transmission
Colistin use in animal production is well-recognized as a driver for the emergence of mcr-positive
bacteria [7]. Bacteria from animal gut and feces play an important role in persistence and transmission
of bacteria that contain mcr genes to humans [40–44]. Bacteria with mcr genes have also been detected
in food products [23], wastewater [45], rivers, seawater [46], and humans [47]. The estimated overall
prevalence in the animal and food samples were higher than in the human samples (Figure 5, Figure 3A),
and this supports the hypothesis of that the food-chain plays a role in mcr transmission. Additional
large-scale investigations in China indicates that aquaculture could be another important reservoir for
food-chain transmission of mcr-harboring bacteria to humans [48–51].
4.2. Role of Plasmids in mcr Dissemination
The mcr genes are generally hosted on bacterial plasmids that are highly mobile and this may
accelerate the spread of resistance under selection pressure [52]. About 61% (123/202) of the articles
have reported the plasmid type which our results were based on. The other articles that have not
mentioned were case reports and surveys. The IncI2, IncX4 and IncHI2 are the most common plasmid
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types that carry mcr genes. While the plasmid IncI2 is common in Asia [53], Oceania [52], North
and South America [54], IncHI2 is more frequently reported in Europe [47] and Africa [24] (Figure 2).
The IncI2 plasmid usually carried the partitioning genes (yafA/yafB), type IV pilus and shuﬄon, acid
resistance and biofilm production, which enhance the conjugation and adherence of the bacteria [55]
with this plasmid to the epithelial cells. Moreover, IncHI2 plasmids are renowned by their ability to
transfer by conjugation in a wide range of temperatures [56]. IncHI2 plasmids are known to carry
several resistance genes, this information shows that even if a change of antimicrobial therapy occurs
during treatment, there will still be a chance to co select for the mcr-1 gene. Also, Several genes, i.e.,
relE and relB (antitoxin system), mucAB (mutagenesis induction system), phi (bacteriophage inhibition),
and colicin, tellurite, and heavy metals together, likely play a key role in the stability of IncHI2
plasmids [57]. The mcr-1 gene is associated with insertion sequence ISApl1 which belongs to IS30
family [58]. A previous study of mcr-1 sequences demonstrated that mcr-1 was part of a ~2609-bp region
flanked by one copy, two copies, or no copies of ISApl1. Recently, Snesrud et al. [59] demonstrated
that all mcr-1 structures can be explained by loss of one, or both, copies of ISApl1 from an ancestral
Tn6330 [60]. Transferable plasmids that harbor mcr genes are detected in isolates of same clonal
backgrounds. The plasmids belonging to the same incompatibility group are likely to be involved in
the dissemination of mcr via the food-chain [61].
4.3. Role of P. E. coli Genotype for mcr Dissemination
Our results show that E. coli ST10 (the most frequent in many continents) and ST101 (widely
distributed among multiple hosts) are the major clones that harbor mcr-1 genes. Our analysis revealed
that ST10 is the dominant ST in both animals and water as mentioned earlier [62]. ST10 and ST101
belong to phylogroups A and B1. These two groups produce enzymes such as ESBLs [63], ampC [64],
carbapenemase, and mBLs [65] that degrade beta lactam antimicrobials. The presence of beta-lactamase
resistance can accelerate the dissemination and persistence of these clones. ST116, with an IncX4
plasmid, is the most abundant clone in human patients, and has not yet been reported in any other
hosts. The IncX4 plasmid in ST116 E. coli strains isolated from humans is likely the result of conjugation
from ST10 strains thatoriginated from water or food [40]. A high rate of conjugation may be enhanced
by the genes essential for synthesis and assembly of the pilus, conjugative function [66,67], and mrk
fimbria [68–70]).
4.4. Rational Antibiotic Choice for mcr-Carrying Bacterial Infections
Isolates that carry mcr genes, and show resistance to colistin, were also frequently shown
to possess other antibiotic-resistant determinants [47]. Interestingly, a few studies reported that
mcr-harboring P. E. coli from human [53] and pig [71] are phenotypically susceptible to colistin in vitro.
This might be attributed to suppression of mcr genes [72], or unknown reasons [73]. Some reports
demonstrated the effectiveness of carbapenem drugs to treat infections caused by colistin-resistant
isolates (Figure 3) [46,47]. The new combination regimen of a carbapenem and tigecycline [74] has also
shown effectiveness against human infections. The resistance of most human clinical K. pneumonia
isolates to multiple antimicrobials is a serious concern [75]. P. E. coli from animal samples did not
show any resistance to tigecycline, except the isolates from pigs. Recently, some studies have reported
that several antibiotics, in combination with colistin, display growth-inhibition at levels below their
corresponding clinical breakpoints such as the combination of colistin and clarithromycin [15] and
colistin and amikacin [76]. Further investigation on effective antibiotic therapies, including combination
therapy, is needed to treat mcr-carrying bacterial infection.
5. Summary
We provide a comprehensive picture of mcr genes from animal hosts, bacterial species, bacterial
genotype, and plasmid types in 47 countries across six continents. The significant role of the food-chain
and/or the environment in mcr gene dissemination and their relationship with other suitable vectors
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(animal hosts, bacteria species, bacterial genotype, plasmid type) warrants further investigations.
Co-resistance of mcr-positive pathogen with other antimicrobials that are critical for the treatment of
drug resistant bacterial infections is an increasing concern, both in human or veterinary medicine.
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